de Vries-van der Zwan A, Besseling A C, de Waal L P, Boog C J
Department of Transplantation Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Blood. 1997 Apr 1;89(7):2596-601.
Bone marrow transfusion is a well-established method for induction of mixed hematopoietic chimerism and donor-specific tolerance in animal models. This procedure, however, is inapplicable in clinical transplantation using cadaveric donors due to the interval (1 week to 7 months) between tolerance induction and organ transplantation. For clinical use, it is essential that allografts be placed at the time of bone marrow transfusion. In the present study, we performed skin transplantation within 1 hour after a nonlethal conditioning regimen. Recipient mice were treated with anti-CD3, anti-CD4, low-dose total body irradiation (3 to 6 Gy TBI) and fully mismatched or haploidentical donor bone marrow cells. Stable multilineage chimerism and specific T-cell nonresponsiveness developed. Donor skin grafts were permanently accepted. These results suggest that this single day protocol has clear potential for application in both cadaveric and living-related organ transplantation.
骨髓输注是在动物模型中诱导混合造血嵌合体和供体特异性耐受的一种成熟方法。然而,由于耐受诱导和器官移植之间的间隔时间(1周至7个月),该方法不适用于使用尸体供体的临床移植。对于临床应用而言,在骨髓输注时植入同种异体移植物至关重要。在本研究中,我们在非致死性预处理方案后1小时内进行了皮肤移植。受体小鼠接受抗CD3、抗CD4、低剂量全身照射(3至6 Gy全身照射)以及完全不匹配或半相合供体骨髓细胞治疗。形成了稳定的多系嵌合体和特异性T细胞无反应性。供体皮肤移植物被永久接受。这些结果表明,这一单日方案在尸体和活体亲属器官移植中具有明确的应用潜力。